Meeting
2012 Gastrointestinal Cancers Symposium
Early thermal quantitative sensory testing to measure acute oxaliplatin neurotoxicity and predict chronic neuropathy in gastrointestinal malignancies.
Authors
Sangeetha Reddy
Northwestern University Feinberg School of Medicine, Chicago, IL
Sangeetha Reddy , Nancy Kwon , Halla Sayed Nimeiri , Mary Frances Mulcahy , Robert Norm Harden , Al Bowen Benson , Judith A. Paice , Maxwell Thomas Vergo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 425)
DOI
10.1200/jco.2012.30.4_suppl.425
Abstract #
425
Poster Bd #
A44
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Using quantitative sensory testing as an early predictor of chronic oxaliplatin neuropathy in gastrointestinal cancer patients.
First Author: Sangeetha Meda Reddy
Poster
2016 Gastrointestinal Cancers Symposium
Oxaliplatin associated neurotoxicity outcomes among older adults with colorectal cancer: A population-based study.
First Author: Michael J. Raphael
Poster
2014 ASCO Annual Meeting
Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance).
First Author: Deirdre R. Pachman
Poster
2022 ASCO Annual Meeting
FORECAST-1: Feasibility of organoid response assessment to define effective treatments for patients with colorectal cancer after failure of standard therapy.
First Author: Margaret Lee